diclofenac has been researched along with bradykinin in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 11 (55.00) | 18.2507 |
| 2000's | 9 (45.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bassenge, E; Busse, R; König, A; Lamontagne, D | 1 |
| Afflerbach, F; Berghöfer, A; Llach Puig Neppl, J; Neppl, H; Neuhof, H | 1 |
| Chulak, C; Couture, R; Foucart, S | 2 |
| Dainaka, J; Hashii, H; Inoue, K; Kimura, K; Motonaga, A; Nishimura, T; Ueda, F; Yamate, K | 1 |
| Hjemdahl, P; Kahan, T; Nussberger, J; Schwieler, JH | 2 |
| Bauersachs, J; Busse, R; Hecker, M | 1 |
| Béa, ML; Berdeaux, A; Ghaleh, B; Giudicelli, JF; Puybasset, L | 1 |
| Andrieu, S; Berdeaux, A; Bévérelli, F; Giudicelli, JF; Lebret, M; Maclouf, J | 1 |
| Bachvarov, DR; Bachvarova, M; Bouthillier, J; Houle, S; Larrivée, JF; Marceau, F | 1 |
| Brandes, RP; Busse, R; Félétou, M; Fleming, I; Gödecke, A; Huang, PL; Schmitz-Winnenthal, FH; Vanhoutte, PM | 1 |
| Alhenc-Gelas, F; Bergaya, S; Bloch-Faure, M; Boulanger, CM; Lévy, BI; Mathieu, E; Meneton, P | 1 |
| Helyes, Z; Horváth, A; Kéri, G; Németh, J; Oroszi, G; Pintér, E; Szolcsányi, J; Thán, M | 1 |
| Ding, Z; Gödecke, A; Schrader, J; Ziegler, M | 1 |
| Hattori, T; Itoh, T; Kajikuri, J; Suzuki, Y; Suzumori, K; Yamamoto, T | 1 |
| Caruso-Neves, C; Fernandes, MS; Leão-Ferreira, LR; Lopes, AG; Quintana-Gomes, E; Santos, DP; Soares, AC | 1 |
| Erhardt, LR; Höglund, P; Jönsson, BA; Juhlin, T; Ottosson, H | 1 |
| Forslid, A; Karnani, P; Liuba, P; Paakkari, I; Persson, K; Pesonen, E | 1 |
| Brerro-Saby, C; Delliaux, S; Jammes, Y; Steinberg, JG | 1 |
1 review(s) available for diclofenac and bradykinin
| Article | Year |
|---|---|
Coronary and systemic hemodynamic effects of sustained inhibition of nitric oxide synthesis in conscious dogs. Evidence for cross talk between nitric oxide and cyclooxygenase in coronary vessels.
Topics: Acetylcholine; Animals; Bradykinin; Coronary Circulation; Coronary Vessels; Diclofenac; Dogs; Epoprostenol; Femoral Artery; Hemodynamics; Hyperemia; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Physical Exertion; Prostaglandin-Endoperoxide Synthases | 1996 |
1 trial(s) available for diclofenac and bradykinin
| Article | Year |
|---|---|
Treatments with losartan or enalapril are equally sensitive to deterioration in renal function from cyclooxygenase inhibition.
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Cyclooxygenase 2 Inhibitors; Diclofenac; Diuretics; Enalapril; Female; Glomerular Filtration Rate; Heart Failure; Humans; Kidney; Losartan; Male; Middle Aged; Renin-Angiotensin System; Time Factors | 2007 |
18 other study(ies) available for diclofenac and bradykinin
| Article | Year |
|---|---|
Prostacyclin and nitric oxide contribute to the vasodilator action of acetylcholine and bradykinin in the intact rabbit coronary bed.
Topics: 6-Ketoprostaglandin F1 alpha; Acetylcholine; Animals; Arginine; Bradykinin; Coronary Circulation; Cyclic AMP; Cyclooxygenase Inhibitors; Diclofenac; Epoprostenol; Female; In Vitro Techniques; Male; Nitric Oxide; Nitroarginine; Rabbits; Vasodilation | 1992 |
Bradykinin-induced oedema formation proceeds from B2 receptor stimulation and is potentiated by concomitantly released prostaglandins.
Topics: Animals; Bradykinin; Capillary Permeability; Diclofenac; Edema; Endothelium, Vascular; Epoprostenol; Female; Male; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Rabbits; Receptors, Bradykinin; Receptors, Neurotransmitter; Vascular Resistance | 1991 |
Modulatory effect of bradykinin on the release of noradrenaline from rat isolated atria.
Topics: Adrenergic beta-Antagonists; Analysis of Variance; Angiotensin II; Animals; Bradykinin; Diclofenac; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Fenoterol; Heart Atria; Indoles; Male; Maleimides; Norepinephrine; Phorbol 12,13-Dibutyrate; Protein Kinase C; Rats; Rats, Wistar | 1995 |
Effect of etodolac on prostaglandin E2 biosynthesis, active oxygen generation and bradykinin formation.
Topics: Animals; Aspirin; Bradykinin; Bromelains; Cartilage, Articular; Cell Line; Concanavalin A; Depression, Chemical; Diclofenac; Dinoprostone; Dogs; Etodolac; Gastric Mucosa; Guinea Pigs; Indomethacin; Interleukin-1; Ketoprofen; Kidney; Naproxen; Oxygen; Pain; Piroxicam; Rabbits; Rats | 1994 |
Participation of prostaglandins and bradykinin in the effects of angiotensin II and converting enzyme-inhibition on sympathetic neurotransmission in vivo.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Diclofenac; Dogs; Electric Stimulation; Female; Norepinephrine; Perfusion; Prostaglandins; Ramipril; Sympathetic Nervous System; Synaptic Transmission; Vasoconstriction | 1994 |
Display of the characteristics of endothelium-derived hyperpolarizing factor by a cytochrome P450-derived arachidonic acid metabolite in the coronary microcirculation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Arachidonic Acid; Arginine; Biological Factors; Bradykinin; Calcium Channel Blockers; Capillaries; Coronary Vessels; Cytochrome P-450 Enzyme System; Diclofenac; Epoprostenol; Female; In Vitro Techniques; Male; Nitric Oxide; Nitroarginine; Nitroprusside; Prostaglandin Endoperoxides, Synthetic; Quinacrine; Rats; Rats, Wistar; Thromboxane A2; Vasoconstrictor Agents; Vasodilation | 1994 |
Converting enzyme inhibition modulates sympathetic neurotransmission in vivo via multiple mechanisms.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Biphenyl Compounds; Blood Pressure; Bradykinin; Diclofenac; Dogs; Epinephrine; Female; Imidazoles; Losartan; Muscle Denervation; Muscles; Norepinephrine; Phenoxybenzamine; Sympathetic Nervous System; Synaptic Transmission; Tetrazoles | 1993 |
Modulatory effect of bradykinin on noradrenaline release in isolated atria from normal and B2 knockout transgenic mice.
Topics: Animals; Bradykinin; Bradykinin Receptor Antagonists; Cyclooxygenase Inhibitors; Diclofenac; Electric Stimulation; Female; Heart; Lysine Carboxypeptidase; Mice; Mice, Knockout; Mice, Transgenic; Myocardium; Norepinephrine; Peptidyl-Dipeptidase A; Prostaglandins; Protein Kinase C; Receptor, Bradykinin B2; Receptors, Bradykinin; Up-Regulation | 1998 |
Effects of antiaggregant and antiinflammatory doses of aspirin on coronary hemodynamics and myocardial reactive hyperemia in conscious dogs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Bradykinin; Coronary Disease; Coronary Vessels; Cyclooxygenase Inhibitors; Diclofenac; Dogs; Dose-Response Relationship, Drug; Hyperemia; Male; Myocardium; Nitric Oxide Synthase; Nitroarginine; Salicylic Acid; Thromboxane B2; Time Factors | 1999 |
Effect of endogenous kinins, prostanoids, and NO on kinin B1 and B2 receptor expression in the rabbit.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bradykinin; Bradykinin Receptor Antagonists; Cyclooxygenase Inhibitors; Diclofenac; Down-Regulation; Duodenum; Enalapril; Female; Gene Expression Regulation; Heart; Histamine; Iloprost; In Vitro Techniques; Kinins; Lipopolysaccharides; Male; Muscle Contraction; Muscle, Smooth, Vascular; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phenylephrine; Prostaglandins; Rabbits; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Receptors, Bradykinin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription, Genetic | 1999 |
An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice.
Topics: Acetylcholine; Animals; Arteries; Biological Factors; Blood Pressure; Bradykinin; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Diclofenac; Endothelium, Vascular; Epoprostenol; Gap Junctions; Gene Deletion; Hindlimb; In Vitro Techniques; Mice; Mice, Inbred C57BL; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Nitroprusside; Perfusion; Potassium Channel Blockers; Potassium Channels; Receptors, Cannabinoid; Receptors, Drug; Vasodilation; Vasodilator Agents | 2000 |
Decreased flow-dependent dilation in carotid arteries of tissue kallikrein-knockout mice.
Topics: Acetylcholine; Animals; Blood Flow Velocity; Bradykinin; Carotid Arteries; Diclofenac; DNA, Complementary; Endothelium, Vascular; Female; Gene Expression; Genotype; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitroprusside; Phenylephrine; Tissue Kallikreins; Vasodilation | 2001 |
Anti-inflammatory effect of synthetic somatostatin analogues in the rat.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Bradykinin; Capillary Permeability; Dextrans; Diclofenac; Dose-Response Relationship, Drug; Evans Blue; Female; Hindlimb; In Vitro Techniques; Inflammation; Injections, Intraperitoneal; Meloxicam; Neuropeptides; Peptides, Cyclic; Rats; Rats, Wistar; Somatostatin; Thiazines; Thiazoles; Time Factors; Trachea; Treatment Outcome | 2001 |
Endothelial dysfunction of coronary resistance vessels in apoE-/- mice involves NO but not prostacyclin-dependent mechanisms.
Topics: Acetylcholine; Adenosine; Analysis of Variance; Animals; Apolipoproteins E; Bradykinin; Cholesterol, LDL; Coronary Vessels; Cyclooxygenase Inhibitors; Diclofenac; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Epoprostenol; Hypercholesterolemia; Iloprost; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Perfusion; Superoxide Dismutase; Vascular Resistance; Vasodilator Agents | 2002 |
Reduced function of endothelial prostacyclin in human omental resistance arteries in pre-eclampsia.
Topics: Adult; Arteries; Bradykinin; Cells, Cultured; Cyclooxygenase Inhibitors; Diclofenac; Electrophysiology; Endothelium, Vascular; Epoprostenol; Female; Humans; In Vitro Techniques; Membrane Potentials; Muscle, Smooth, Vascular; Omentum; Pre-Eclampsia; Pregnancy; Vascular Resistance; Vasoconstriction; Vasodilator Agents | 2002 |
PLA2/PGE2 are involved in the inhibitory effect of bradykinin on the angiotensin-(1-7)-stimulated Na(+)-ATPase activity of the proximal tubule.
Topics: Angiotensin I; Animals; Bradykinin; Bradykinin B2 Receptor Antagonists; Cell Membrane; Cyclooxygenase Inhibitors; Diclofenac; Dinoprostone; Dose-Response Relationship, Drug; Indomethacin; Kidney Tubules, Proximal; Peptide Fragments; Phospholipases A; Phospholipases A2; Quinacrine; Receptor, Bradykinin B2; Sodium-Potassium-Exchanging ATPase; Swine | 2004 |
Effects of bradykinin on aortic endothelial function in apoe-knockout mice with chronic Chlamydia pneumoniae infection.
Topics: Animals; Aorta; Apolipoproteins E; Bradykinin; Chlamydophila Infections; Chlamydophila pneumoniae; Cyclooxygenase Inhibitors; Diclofenac; Endothelium, Vascular; Enzyme Inhibitors; Methacholine Chloride; Mice; Mice, Knockout; Muscarinic Agonists; NG-Nitroarginine Methyl Ester; Nitric Oxide; Time Factors; Vasodilation; Vasodilator Agents | 2007 |
Reactive oxygen species and inflammatory mediators enhance muscle spindles mechanosensitivity in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bradykinin; Diclofenac; Electric Stimulation; Electrophysiology; Humans; Hydrogen Peroxide; Inflammation Mediators; Interleukin-6; Isoprostanes; Mechanotransduction, Cellular; Muscle Fatigue; Muscle Spindles; Oxidants; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Superoxide Dismutase; Vasodilator Agents | 2009 |